Recombinant Influenza A Virus Hemagglutinin H3 protein (ab69750)

製品の概要

法規制情報

製品の詳細

  • 由来Recombinant
  • 由来Baculovirus infected insect cells

特性

Our Abpromise guarantee covers the use of ab69750 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    Western blot

    ELISA

  • 精製度> 90 % SDS-PAGE.
    Purity is greater than 90.0% as determined by SDS-PAGE. Filter sterilised.
  • 製品の状態Liquid
  • 備考


    H3N2 descended from H2N2 by antigenic shift and has tended to dominate in prevalence over H1N1, H1N2, and influenza B. Both the H2N2 and H3N2 strains contained genes from avian influenza viruses.

  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Store at +4°C.

    Preservative: None
    Constituents: 0.005% Tween 20, 150mM Sodium chloride, 10mM Sodium phosphate, pH 7.4

関連情報

  • 関連性Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes.

Recombinant Influenza A Virus Hemagglutinin H3 protein (ab69750) 使用論文

ab69750 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab69750.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"